Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu)
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2515
https://www.valueinhealthjournal.com/article/S1098-3015(15)04591-X/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
2391
First Page :
A766
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04591-X&doi=10.1016/j.jval.2015.09.2515